Microtubule-stabilizing agents: a growing class of important anticancer drugs

被引:127
作者
Altmann, KH [1 ]
机构
[1] Novartis Pharma AG, Corp Res, CH-4002 Basel, Switzerland
关键词
D O I
10.1016/S1367-5931(00)00225-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Microtubule-stabilizing agents continue to play an important role in anticancer drug discovery and development. New agents were again discovered in the past year, including small synthetic molecules. At least three new taxanes and two compounds of the epothilone class of natural products underwent clinical trials in 2000. Unexpected new findings about synergistic effects between different microtubule-stabilizing agents in vitro raise new prospects for combination chemotherapy.
引用
收藏
页码:424 / 431
页数:8
相关论文
共 64 条
  • [21] Harris CR, 1999, J ORG CHEM, V64, P8434
  • [22] The role of interleukin-2 in regulating the sensitivity of natural killer cells for Fas-mediated apoptosis
    Haux, J
    Johnsen, AC
    Steinkjer, B
    Egeberg, K
    Sundan, A
    Espevik, T
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 1999, 48 (2-3) : 139 - 146
  • [23] (+)-discodermolide binds to microtubules in stoichiometric ratio to tubulin dimers, blocks taxol binding and results in mitotic arrest
    Hung, DT
    Chen, J
    Schreiber, SL
    [J]. CHEMISTRY & BIOLOGY, 1996, 3 (04): : 287 - 293
  • [24] Synthesis, structure proof, and biological activity of epothilone cyclopropanes
    Johnson, J
    Kim, SH
    Bifano, M
    DiMarco, J
    Fairchild, C
    Gougoutas, J
    Lee, F
    Long, B
    Tokarski, J
    Vite, G
    [J]. ORGANIC LETTERS, 2000, 2 (11) : 1537 - 1540
  • [25] Microtubules and actin filaments: dynamic targets for cancer chemotherapy
    Jordan, MA
    Wilson, L
    [J]. CURRENT OPINION IN CELL BIOLOGY, 1998, 10 (01) : 123 - 130
  • [26] KADOW JF, 2000, 219 ACS NAT M SAN FR
  • [27] KIM SH, 1999, Patent No. 9928324
  • [28] New synthetic inhibitors of microtubule depolymerization
    Klar, U
    Graf, H
    Schenk, O
    Röhr, B
    Schulz, H
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (11) : 1397 - 1402
  • [29] Kowalski RJ, 1997, J BIOL CHEM, V272, P2534
  • [30] The microtubule-stabilizing agent discodermolide competitively inhibits the binding of paclitaxel (Taxol) to tubulin polymers, enhances tubulin nucleation reactions more potently than paclitaxel, and inhibits the growth of paclitaxel-resistant cells
    Kowalski, RJ
    Giannakakou, P
    Gunasekera, SP
    Longley, RE
    Day, BW
    Hamel, E
    [J]. MOLECULAR PHARMACOLOGY, 1997, 52 (04) : 613 - 622